Navigation Links
Life Science Research Tools Market Size, Growth and Trends 2006-2016

DUBLIN, March 8, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Life Science Research Tools Market Size, Growth and Trends 2006-2016" report to their offering.


This report provides an overview of the life sciences research tools market from 2006 to 2016. Life sciences research tools companies offer instruments, reagents and services to scientists in academic, BioPharma and applied market laboratories. Top vendors include Agilent, Bio-Rad, EMD Millipore, Life Technologies (Invitrogen / Applied Biosystems), Roche, Sigma-Aldrich and Thermo Fisher ; smaller emerging players are highlighted as well (e.g., genomics players [Fluidigm, Raindance, Oxford Nanopore, NABSys, GnuBio]). Segmenting the market by technology, we estimate that the life science research tools market reached $37.4B in 2011, and is expected to grow -4% p.a. in the next 5 years.

Many reports on individual technologies report bullish growth rates of 5%-20% for Academic, BioPharma and Applied market customers (and excluding in vitro diagnostics). While our analysis confirms that applied market might experience double digit growth for many technologies, current market size estimates for these customers do not support an overall market growth of 10% for the overall life science research tools sector. This is especially true in light of the current global economic slowdown (including in India and China) and continued sovereign-debt crisis in Europe. A review of public fillings and guidance from the top players in this space -as well as an analysis of the funding reality in Academia and BioPharma- confirms this outlook.

This report evaluates which technologies are expected to capture and lose market share in this mid-single digit growth rate market. In this second edition, we updated our analysis to reflect the most current market sales and trends in 5 broad segments:

1) Pure genomics technologies: qPCR, next generation sequencing (NGS) / third generation sequencing (3GS), microarrays, PCR, CE sequencing, molecular biology tools, digital PCR;

2) Pure proteomics technologies: protein isolation and analysis, ELISA, protein production, western blots and protein microarrays;

3) Cell biology technologies: discovery services, basic cell biology reagents, flow cytometry, transfection and electroporation, media and sera, microscopy, cell culture equipment, whole cell analysis, cells and tissues, high content imaging;

4) Other analytical technologies: liquid chromatography, mass spectroscopy, structural analysis methods, in vivo study, spectroscopy, multiplex technologies, label free technologies;

5) Other supplies and technologies: lab supplies and disposables, glassware, automation, sample preparation, LIMS, magnetic beads. For each of these 35 subsegments, we present an analysis detailing sales of instruments and reagents for 2006, 2011 and 2016.

In addition, we detail market drivers and moderators, market trends, a high level end-customer breakdown (Academic, BioPharma and Applied markets customers) and key competitors. Many of these technologies are increasingly used for clinical diagnostics purposes. Therefore, we briefly cover the size, growth and trends of the in vitro diagnostics and molecular diagnostics markets. All data are based on manufacturer sales as publically reported, and interviews with life sciences experts in academic, BioPharma and applied market laboratories.

Companies Mentioned

- Agilent
- Bio-Rad
- EMD Millipore
- Invitrogen / Applied Biosystems
- Roche
- Sigma-Aldrich
- Thermo Fisher
- Fluidigm
- Raindance
- Oxford Nanopore
- NABSys
- GnuBio

For more information visit

Research and Markets
Laura Wood , Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +1-353-1-481-1716
Sector: Pharmaceuticals

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
2. Cardiac Science Celebrates 100-Year Anniversary
3. Good Science from RegenceRx Equals Good Value for Michigans Upper Peninsula Health Plan
4. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
5. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
6. Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration
7. Dr. Joachim Schorr (PhD) zum Chief Scientific Officer von Caris Life Sciences bestellt
8. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
9. Oregon Health & Science University Receives Award For Leadership In Advanced Healthcare Technology Solutions
10. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
11. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
Post Your Comments:
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from reveals that behind the tendency to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):